Non-Coding RNAs as Emerging Biomarkers in Leishmaniasis and Chagas Disease. [PDF]
Ramos Juárez E +15 more
europepmc +1 more source
Topical microemulsion with phenolic compounds from Libidibia ferrea (Fabaceae): An alternative treatment for cutaneous leishmaniasis. [PDF]
Jensen BB +10 more
europepmc +1 more source
Comparative histopathological and immunological analysis of LRV2-positive and LRV2-negative Leishmania tropica in a BALB/c mouse cutaneous leishmaniasis model. [PDF]
Öztatlıcı M +3 more
europepmc +1 more source
Unusual report of an immunocompetent patient with atypical cutaneous leishmaniasis caused by Leishmania (Leishmania) infantum in Minas Gerais, Brazil. [PDF]
Rocha RM +15 more
europepmc +1 more source
Mechanisms of Immune Evasion, Dissemination, and Persistence in Leishmania amazonensis Infection. [PDF]
Portugal AB +3 more
europepmc +1 more source
Antileishmanial and Immunomodulatory Activity of Paclitaxel and Docetaxel Combined with Miltefosine and Paromomycin. [PDF]
Melcón-Fernández E +6 more
europepmc +1 more source
[A study of experimental cutaneous leishmaniasis in white mice].
openaire +1 more source
Related searches:
Leishmania major: Activity of tamoxifen against experimental cutaneous leishmaniasis
Experimental Parasitology, 2011Leishmaniasis is a family of diseases caused by protozoan parasites of the genus Leishmania. Various Leishmania species can cause human infection, producing a spectrum of clinical manifestations. The current treatments are unsatisfactory, and in absence of a vaccine, there is an urgent need for effective drugs to replace/supplement those currently in ...
Maha M Eissa
exaly +3 more sources
Experimental cutaneous leishmaniasis
Acta Tropica, 1997Lourdes Maria Garcez +4 more
exaly +2 more sources

